Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Scelsi

Showing results (91-100 of 123) with videos related to

Pageof 13
Sort By:
Giornale Italiano Di Cardiologia (2006)|February 27, 2024
[ANMCO/SIC Consensus statement on pulmonary arterial hypertension]Marco Vatrano, Giovanna Manzi, Claudio Picariello, et al.
Vascular Pharmacology|September 12, 2024
Gaps in evidence in the treatment of prevalent patients with pulmonary arterial hypertension at intermediate risk: An expert consensusGiovanna Manzi, Raymond L Benza, Paola Argiento, et al.
International Journal of Cardiology|January 9, 2022
Benefit from sacubitril/valsartan is associated with hemodynamic improvement in heart failure with reduced ejection fraction: An echocardiographic studyErberto Carluccio, Frank L Dini, Roberto Bitto, et al.
Giornale Italiano Di Cardiologia (2006)|November 22, 2016
[ANMCO Position paper: Recommendations for the follow-up of patients with pulmonary thromboembolism]Carlo D'Agostino, Pietro Zonzin, Iolanda Enea, et al.
ESC Heart Failure|February 5, 2022
Echocardiographically defined haemodynamic categorization predicts prognosis in ambulatory heart failure patients treated with sacubitril/valsartanFrank L Dini, Erberto Carluccio, Roberto Bitto, et al.
American Journal of Respiratory and Critical Care Medicine|August 29, 2020
Risk Reduction and Hemodynamics with Initial Combination Therapy in Pulmonary Arterial HypertensionRoberto Badagliacca, Michele D'Alto, Stefano Ghio, et al.
European Heart Journal Supplements : Journal of the European Society of Cardiology|July 29, 2017
ANMCO Position Paper: long-term follow-up of patients with pulmonary thromboembolismCarlo D'Agostino, Pietro Zonzin, Iolanda Enea, et al.
ERJ Open Research|November 16, 2022
Relevance of comorbidities on initial combination therapy in pulmonary arterial hypertensionRoberto Badagliacca, Michele D'Alto, Stefano Ghio, et al.
European Heart Journal. Imaging Methods and Practice|January 16, 2025
Echocardiography of the right heart in pulmonary arterial hypertension: insights from the ULTRA RIGHT VALUE studyFrancesco Lo Giudice, Pilar Escribano-Subias, Khodr Tello, et al.
Circulation|October 2, 2013
Anticoagulation and survival in pulmonary arterial hypertension: results from the Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension (COMPERA)Karen M Olsson, Marion Delcroix, H Ardeschir Ghofrani, et al.
Pageof 13

Showing results (91-100 of 123) with videos related to

Sort By:
Pageof 13
Giornale Italiano Di Cardiologia (2006)|February 27, 2024
[ANMCO/SIC Consensus statement on pulmonary arterial hypertension]Marco Vatrano, Giovanna Manzi, Claudio Picariello, et al.
Vascular Pharmacology|September 12, 2024
Gaps in evidence in the treatment of prevalent patients with pulmonary arterial hypertension at intermediate risk: An expert consensusGiovanna Manzi, Raymond L Benza, Paola Argiento, et al.
International Journal of Cardiology|January 9, 2022
Benefit from sacubitril/valsartan is associated with hemodynamic improvement in heart failure with reduced ejection fraction: An echocardiographic studyErberto Carluccio, Frank L Dini, Roberto Bitto, et al.
Giornale Italiano Di Cardiologia (2006)|November 22, 2016
[ANMCO Position paper: Recommendations for the follow-up of patients with pulmonary thromboembolism]Carlo D'Agostino, Pietro Zonzin, Iolanda Enea, et al.
ESC Heart Failure|February 5, 2022
Echocardiographically defined haemodynamic categorization predicts prognosis in ambulatory heart failure patients treated with sacubitril/valsartanFrank L Dini, Erberto Carluccio, Roberto Bitto, et al.
American Journal of Respiratory and Critical Care Medicine|August 29, 2020
Risk Reduction and Hemodynamics with Initial Combination Therapy in Pulmonary Arterial HypertensionRoberto Badagliacca, Michele D'Alto, Stefano Ghio, et al.
European Heart Journal Supplements : Journal of the European Society of Cardiology|July 29, 2017
ANMCO Position Paper: long-term follow-up of patients with pulmonary thromboembolismCarlo D'Agostino, Pietro Zonzin, Iolanda Enea, et al.
ERJ Open Research|November 16, 2022
Relevance of comorbidities on initial combination therapy in pulmonary arterial hypertensionRoberto Badagliacca, Michele D'Alto, Stefano Ghio, et al.
European Heart Journal. Imaging Methods and Practice|January 16, 2025
Echocardiography of the right heart in pulmonary arterial hypertension: insights from the ULTRA RIGHT VALUE studyFrancesco Lo Giudice, Pilar Escribano-Subias, Khodr Tello, et al.
Circulation|October 2, 2013
Anticoagulation and survival in pulmonary arterial hypertension: results from the Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension (COMPERA)Karen M Olsson, Marion Delcroix, H Ardeschir Ghofrani, et al.
Pageof 13